Hear Why Industry Leaders Choose World ADC
"What stands out the most is the opportunity to contextualize, at a global level, the status and trends of the ADC landscape. Everything is very well organized, and the presentations are insightful”
AstraZeneca
“Best ADC event in Europe”
Pierre Fabre
“An excellent opportunity to listen to the subject matter experts and gaining knowledge”
Arcadis
“Well organized, catered, with rich access to industry expertise through the various conference streams”
BioDlink
“Very nice and comprehensive overview of the ADC field!”
Crossfire Oncology
“Great presentations, and a chance to have offline discussions”
Daiichi Sankyo
“The APP was very useful to follow-up the diverse and wide program”
Debiopharm
“High scientific level in all the presentations and easy to connect in the break out sessions. It has the right size and the app made really easy to navigate the conference”
Worldwide Clinical Trials
“I appreciate the high scientific quality and the strong focus on real-world challenges in ADC development. The integration of academic, industry, and investor perspectives make the experience particularly valuable”
Exiris
“I really enjoy the variety of talks within the pipeline of ADCs and the panel discussions”
GSK
“Excellent speakers and various networking opportunities to connect with others”
H Linkers
“Knowledgeable attendees provided a great cross section of current ADC research and development”
Iksuda Therapeutics
“Attending for the first time, I felt I received a very through and realistic view on the ADC field”
Orion Pharma
“The high scientific quality of presentations and of the discussions and the strong focus on innovation within the ADC field”
OncoBone Therapeutics
“Clear overview on new developments in ADC technology”
Nona Biosciences
“Comprehensive information on ADC research and development”
Merck & Co
“The opportunity to network with some of the heaviest hitters in the industry and meet with prospective Clients in London is not to be missed”
Mabplex
“The ADC focus of the conference allows for a focused discussion of key topics and advances in the field and brings subject matter experts together in a smaller conference that some of the larger conferences we would normally attend”
Kivu BioScience
“A bright, spacious environment with sharp, targeted presentations, insightful KOLs addressing key market issues, and top‑tier scientific conferences”
Jubilant Biosys
“Excellent talks with very exciting topics including preclinical and clinical data”
Innate Pharma
Explore the Preliminary Agenda
- 700+ ADC Industry Leaders Across Biopharma, Academia & Solution Providers
- 90+ Global ADC Experts & Industry Visionaries
- 5 Tracks of End-to-End ADC Innovation
- Brand-New Partnering Platform & Enhanced Networking Experiences
- Europe's Largest Gathering of the ADC Community
